These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 897781)

  • 1. [Dihydrotachysterol in treatment of patients with hypoparathyroidism].
    Gincherman EZ; Stoilov LD; Avakumov VM; Kruglikova-L'vova RP
    Sov Med; 1977 Jun; (6):58-60. PubMed ID: 897781
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of hypoparathyroidism with dihydrotachysterol].
    Furukawa Y
    Nihon Rinsho; 1972 Feb; 30(2):646-51. PubMed ID: 5062758
    [No Abstract]   [Full Text] [Related]  

  • 3. [Primary hypoparathyroidism resistant to treatment with vitamin D3, 25-hydroxycholecalciferol and dihydrotachysterol. Efficacy of treatment with 1 alpha,25-dihyroxycholecalciferol].
    Sanmartí Sala A; Recas Planellas I; Tresánchez Trías JM; Mesa Manteca J; Bonal Bastons J; Foz Sala M
    Med Clin (Barc); 1983 Apr; 80(12):541-4. PubMed ID: 6306361
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical observations on the action of dihydrotachysterol (AT 10) in secondary hypoparathyroidism].
    Losana O; Olivetti M; Molinatti GM
    Minerva Med; 1967 Nov; 58(90):3867-70. PubMed ID: 6078628
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of hypoparathyroidism with dihydrotachysterol].
    Gincherman EZ; Stoilov LD
    Probl Endokrinol (Mosk); 1974; 20(6):39-42. PubMed ID: 4449814
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hypoparathyroidism].
    Fujita T
    Naika; 1971 Jun; 27(6):1190-3. PubMed ID: 4326409
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of hypoparathyroidism].
    Fujita T; Orimo H; Ota M; Okano K; Yoshikawa M
    Nihon Rinsho; 1969 May; 27(5):1477-82. PubMed ID: 5817508
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison between crystalline dihydrotachysterol and calciferol in patients requiring pharmacologic vitamin D therapy.
    Harrison HE; Lifshitz F; Blizzard RM
    N Engl J Med; 1967 Apr; 276(16):894-900. PubMed ID: 5297643
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of vitamin D-resistant hypoparathyroidism with 25-hydroxycholecalciferol.
    Pak CY; DeLuca HF; Chavez de los Rios JM; Suda T; Ruskin B; Delea CS
    Arch Intern Med; 1970 Aug; 126(2):239-47. PubMed ID: 4317441
    [No Abstract]   [Full Text] [Related]  

  • 10. [Subacute idiopathic hypoparathyroidism].
    Concouris L; Panayotopoulos E
    Ann Med Interne (Paris); 1970 Dec; 121(12):1079-80. PubMed ID: 5504238
    [No Abstract]   [Full Text] [Related]  

  • 11. Crystalline dihydrotachysterol (Dygratyl) in the treatment of hypoparathyroidism.
    Dymling JF; Ryd H
    Acta Med Scand; 1968 Oct; 184(4):333-6. PubMed ID: 5304511
    [No Abstract]   [Full Text] [Related]  

  • 12. [Nephrocalcinosis caused by dihydrotachysterol therapy].
    Forsström J; Kasanen A; Sutinen S
    Duodecim; 1971; 87(19):1331-6. PubMed ID: 5133057
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical effects of 1 alpha-hydroxycholecalciferol (alpha-D3) in hypoparathyroidism--comparison with dihydrotachysterol (DHT2)--multi-institutional double blind studies].
    Fujita T; Furukawa Y; Son T; Ogata E; Fujimoto Y
    Horumon To Rinsho; 1979 Jan; 27(1):99-113. PubMed ID: 218756
    [No Abstract]   [Full Text] [Related]  

  • 14. Dihydrotachysterol therapy for hypoparathyroidism: consequences of inadequate monitoring. Five cases and a review.
    Quack I; Zwernemann C; Weiner SM; Sellin L; Henning BF; Waldherr R; Büchner NJ; Stegbauer J; Vonend O; Rump LC
    Exp Clin Endocrinol Diabetes; 2005 Jul; 113(7):376-80. PubMed ID: 16025398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Various types of hypoparathyroidism and their treatment].
    Okano K; Nakai R; Tomori T; Yoshikawa M
    Horumon To Rinsho; 1978 Apr; 26(4):371-7. PubMed ID: 306900
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of vitamin D and dihydrotachysterol in medicine].
    Courvoisier B
    Ther Umsch; 1969 Nov; 26(11):629-32. PubMed ID: 5355781
    [No Abstract]   [Full Text] [Related]  

  • 17. [Behavior of ultra-filtrable serum calcium in parathyroid insufficiency following dihydrotachysterol administration. Animal experimental studies of a clinical phenomenon].
    Ponsold W; Pfordte K
    Dtsch Gesundheitsw; 1969 Mar; 24(8):376-8. PubMed ID: 5376408
    [No Abstract]   [Full Text] [Related]  

  • 18. The early effects of dihydrotachysterol on calcium and phosphorus metabolism in patients with hypoparathyroidism.
    Hunt G; Morgan DB
    Clin Sci; 1970 Jun; 38(6):713-25. PubMed ID: 5431603
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical application of dihydrotachysterol in various types of hypocalcemia].
    Nakajima N; Hoshina K; Nakata M
    Nihon Rinsho; 1972 Mar; 30(3):814-22. PubMed ID: 4338914
    [No Abstract]   [Full Text] [Related]  

  • 20. [Chronic hypocalcemic encephalopathy in idiopathic hypoparathyroidism].
    Ovcharova P; Raĭchev R; Kostov K
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(12):1782-8. PubMed ID: 6000478
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.